Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs FBDIX overlap: 18% of top holdings shared

Bottom line

How much do XBI and FBDIX overlap?

18% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 7.4% of XBI's assets and 12.3% of FBDIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

XBIFBDIX
Weight overlap (top 25)18%
Shared holdings6
Weight in shared holdings7.4%12.3%
Total positions161126
Expense ratio0.35%1.01%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XBI and FBDIX have in common

Holding% of XBI% of FBDIXOverlap
Oruka Therapeutics Inc1.38%1.86%1.38%
Praxis Precision Medicines Inc1.29%1.91%1.29%
Revolution Medicines Inc1.20%3.01%1.20%
Dianthus Therapeutics Inc1.18%2.32%1.18%
Cytokinetics Inc1.18%1.24%1.18%
Mirum Pharmaceuticals Inc1.16%1.98%1.16%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Kymera Therapeutics Inc — 1.36%
  6. Viking Therapeutics Inc — 1.30%
  7. Erasca Inc — 1.27%
  8. Rhythm Pharmaceuticals Inc — 1.20%
  9. CG oncology Inc — 1.20%
  10. SELLAS Life Sciences Group Inc — 1.19%
  11. Vaxcyte Inc — 1.19%
  12. Natera Inc — 1.16%
  13. Scholar Rock Holding Corp — 1.16%
  14. Roivant Sciences Ltd — 1.16%
  15. Cogent Biosciences Inc — 1.14%

Only in FBDIX

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Guardant Health, Inc. — 2.76%
  9. Ascendis Pharma A/S — 2.56%
  10. Insmed, Inc. — 1.99%
  11. Spyre Therapeutics, Inc. — 1.87%
  12. Neurocrine Biosciences, Inc. — 1.82%
  13. Bridgebio Pharma, Inc. — 1.67%
  14. PTC Therapeutics, Inc. — 1.65%
  15. AstraZeneca plc — 1.51%

Asset mix

Asset typeXBIFBDIX
Stocks99.9%97.0%
Cash & short-term funds5.9%4.6%
Preferred stock—1.0%
Other—0.6%
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXBIFBDIX
US100.8%82.0%
IE1.2%6.7%
NL1.0%4.5%
DK—2.6%
FR—1.7%
GB—1.5%
CA0.2%1.3%
CH1.0%1.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XBI and FBDIX overlap?
About 18% by weight. 6 securities appear in both funds' top 25 holdings; they make up 7.4% of XBI's assets and 12.3% of FBDIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and FBDIX have in common?
The largest shared holdings are Oruka Therapeutics Inc, Praxis Precision Medicines Inc, Revolution Medicines Inc, Dianthus Therapeutics Inc, Cytokinetics Inc.
Should I own both XBI and FBDIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or FBDIX?
XBI is broader, with 161 positions versus 126 for FBDIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.